Alexandra Coomans de Brachène

5PUBLICATIONS
2CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 27, 2024
Interferons are key cytokines acting on pancreatic islets in type 1 diabetes.

Alexandra Coomans de Brachène, Maria Ines Alvelos, Florian Szymczak

|Nov 19, 2022
Exercise as a non-pharmacological intervention to protect pancreatic beta cells in individuals with type 1 and type 2 diabetes.

Alexandra Coomans de Brachène, Corentin Scoubeau, Anyïshai E Musuaya

|Mar 28, 2021
Endogenous mitochondrial double-stranded RNA is not an activator of the type I interferon response in human pancreatic beta cells.

Alexandra Coomans de Brachène, Angela Castela, Anyïshai E Musuaya

|Jun 02, 2020
Preclinical evaluation of tyrosine kinase 2 inhibitors for human beta-cell protection in type 1 diabetes.

Alexandra Coomans de Brachène, Angela Castela, Anne Op de Beeck

|Jan 07, 2018
IFN-α induces a preferential long-lasting expression of MHC class I in human pancreatic beta cells.

Alexandra Coomans de Brachène, Reinaldo S Dos Santos, Laura Marroqui

Pageof 1